Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Novartis terminates plant contract with Chinese CDMO Porton, threatens $64 million legal claim
By healthadmin
Novartis’ cross-border partnerships are at odds. A Swiss pharmaceutical company has unilaterally terminated its factory…
Even as the specter of new drug prices looms over President Donald Trump’s Most Favored…
AstraZeneca also uses approved sweetener for Fasenra, granted important FDA nod in hypertension
By healthadmin
After showing impressive Phase 3 results last fall, AstraZeneca’s bet on Cincor Pharma and its…
In the past 18 months, Merck and Cologne Biotech have secured four approvals in China…
Eli Lilly is setting up a huge manufacturing facility in Houston, but it’s not the…
First, AstraZeneca’s Enhertz receives double FDA approval to treat early-stage breast cancer
By healthadmin
Enhertu’s market conquest continues apace. Daiichi Sankyo and AstraZeneca’s star antibody-drug conjugate, which already has…
The case for direct patient care is clear, but the challenge ahead is successful implementation
By healthadmin
Direct-to-patient (DTP) claims are clearly stated. Unify the prescription process and create a frictionless, branded…
Doceree launches Daily Command, an AI platform for brand teams co-built by pharmaceutical industry leaders
By healthadmin
Doceree has bold ambitions to bring pharma brand teams a new software category that reimagines…
Roche’s ctDNA-based approach to postoperative bladder cancer delivers results with Tecentriq agreement
By healthadmin
With help from DNA testing company Natera and its personalized molecular residual disease (MRD) blood…
While outgoing Commissioner Marty McCulley’s resignation is still pending, another top regulator may be on…